Episode Details

Back to Episodes
Pharmaceutical Executive Daily: Mike Doustdar Open to Direct Listing for Novo Shares

Pharmaceutical Executive Daily: Mike Doustdar Open to Direct Listing for Novo Shares

Published 1 month, 3 weeks ago
Description
EVERSANA's Jen Norton talks about how AI is reshaping market access strategy, a new analysis from MIT and Harvard Business School names clinical data harmonization as the real barrier to enterprise AI adoption in life sciences, and Novo Nordisk's CEO says he's open to a direct NYSE listing.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us